Sangamo Therapeutics Inc 's ability to collect accounts receivable sequentially worsen to 64.62, indicating more challenging environment then in the fourth quarter 2025, but still, it is a far cry from any concerns. Sangamo Therapeutics Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 6 days, from 4 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 351 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 1874 to 2489.

What is Receivable Turnover Ratio?
What is Sangamo Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

SGMO Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	138.52 %	-29.47 %	-95.02 %	-35.97 %	-47.03 %
Y / Y Revenue Change	-77.6 %	88.43 %	-98.82 %	5042.13 %	1238.25 %
Receivable Turnover Ratio (TTM)	64.62	96.94	73.59	27.79	21.31
SGMO's Total Ranking	# 2489	# 1874	# 1821	# 711	# 864
Accounts Receivable average collection period days	6	4	5	13	17
Seq. Receivable Change	135.31 %	-29.06 %	40.59 %	1.64 %	-30.42 %
Seq. Revenue Change	-89.87 %	2348.88 %	-96.83 %	184.39 %	-14.75 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 36
Healthcare Sector	# 352
Overall Market	# 2489

Receivable Turnover Ratio Statistics
High	Average	Low
46.81	12.24	5.06
(Dec 31 2023)		(Dec 31 2019)

SGMO Company Profile • Back to SGMO Efficiency Comparisons • Compare SGMO Receivables Turnover Ratio to its Competitors

Financial Statements
Sangamo Therapeutics Inc 's Accounts Receivable	$ 1 Millions	Visit SGMO's Balance sheet
Sangamo Therapeutics Inc 's Sales TTM	$ 35 Millions	Visit SGMO's Income Statement
Sources of SGMO's Revenues		Visit SGMO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
SGMO's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
SGMO's Growth Rates	SGMO's Roa	SGMO's Inventory Turnover Ratio	SGMO's Dividend Comparisons
SGMO's Profitability Ratios	SGMO's Roi	SGMO's Asset Turnover Ratio	SGMO's Dividend Growth
SGMO's Valuation Ratios	SGMO's Roe	SGMO's Financial Strength Ratios	SGMO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Harvard Apparatus Regenerative Technology Inc	88.50	$ 0.885 Millions	$ 0.010 Millions
Zeo Scientifix Inc	74.53	$ 6.987 Millions	$ 0.094 Millions
Airsculpt Technologies Inc	69.52	$ 151.836 Millions	$ 2.184 Millions
Lifevantage Corp	67.74	$ 193.618 Millions	$ 2.858 Millions
Sbc Medical Group Holdings Incorporated	64.95	$ 167.536 Millions	$ 2.579 Millions
Arrowhead Pharmaceuticals Inc	63.74	$ 622.009 Millions	$ 9.758 Millions
Hims and Hers Health Inc	63.35	$ 2,369.476 Millions	$ 37.405 Millions
Spero Therapeutics Inc	59.36	$ 61.186 Millions	$ 1.031 Millions
Humacyte Inc	58.59	$ 34.376 Millions	$ 0.587 Millions
Aim Immunotech Inc	53.71	$ 0.094 Millions	$ 0.002 Millions
Brookdale Senior Living Inc	49.21	$ 3,145.058 Millions	$ 63.914 Millions
Fortrea Holdings Inc	44.31	$ 2,708.600 Millions	$ 61.125 Millions
National Vision Holdings Inc	41.80	$ 2,021.044 Millions	$ 48.351 Millions
Metagenomi Therapeutics Inc	41.78	$ 22.331 Millions	$ 0.535 Millions
Mangoceuticals Inc	41.34	$ 0.415 Millions	$ 0.010 Millions
Nature s Sunshine Products inc	39.69	$ 489.104 Millions	$ 12.324 Millions
Longduoduo Co Ltd	35.04	$ 2.132 Millions	$ 0.061 Millions
Innovative Eyewear Inc	33.59	$ 2.981 Millions	$ 0.089 Millions
Electrocore Inc	32.90	$ 34.458 Millions	$ 1.047 Millions
U S Physical Therapy Inc	30.94	$ 795.488 Millions	$ 25.708 Millions
Invo Fertility Inc	29.40	$ 7.219 Millions	$ 0.246 Millions
Lineage Cell Therapeutics Inc	28.42	$ 14.779 Millions	$ 0.520 Millions
Meiragtx Holdings Plc	28.01	$ 79.758 Millions	$ 2.848 Millions
Innovage Holding Corp	27.55	$ 949.172 Millions	$ 34.455 Millions
Cv Sciences Inc	27.37	$ 11.925 Millions	$ 0.436 Millions
Wave Life Sciences Ltd	27.36	$ 88.173 Millions	$ 3.223 Millions
Safe Pro Group Inc	27.29	$ 1.642 Millions	$ 0.060 Millions
Atara Biotherapeutics Inc	27.03	$ 23.540 Millions	$ 0.871 Millions
Biorestorative Therapies Inc	25.41	$ 0.363 Millions	$ 0.014 Millions
Jaguar Health Inc	24.65	$ 29.569 Millions	$ 1.200 Millions

Date modified: 2026-09-08T15:11:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.